{
    "2019-10-10": [
        [
            {
                "time": "",
                "original_text": "自主疫苗业务稳定增长，沃森生物前三季净利预计超亿元",
                "features": {
                    "keywords": [
                        "疫苗",
                        "沃森生物",
                        "净利",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：13价肺炎疫苗处于审批尾声 买入评级",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "肺炎疫苗",
                        "审批",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：预计前三季度净利润同比增长29%-43%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "增长",
                        "前三季"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：前三季净利预增29%-43%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利",
                        "预增",
                        "前三季"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：前三季度净利润预增29%-43%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "预增",
                        "前三季度"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)第三季度净利润预增84%-151%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利润",
                        "预增",
                        "第三季度"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}